Gluten Intolerance Treatment Market Outlook:
Gluten Intolerance Treatment Market size was valued at USD 935.53 million in 2025 and is set to exceed USD 3.41 billion by 2035, expanding at over 13.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of gluten intolerance treatment is estimated at USD 1.05 billion.
The market growth is backed by the growing research on how to reverse gluten intolerance. This is resulting in the rise in clinical trials and the development of workable gluten intolerance treatments.
The rising incidence of gluten-related disorders (GRDs) and the rise in their global prevalence is predicted in about 5% of the population. The ingestion of the gluten proteins present in wheat, barley, and rye is considered the main cause of GRDs. GRDs refer to a group of conditions that are heterogeneous, reflecting their autoimmune, allergic, and non-autoimmune-allergic etiology. The increasing adoption of gluten intolerance treatment by people suffering from GRDs is will positively impact the growth of the market.
Key Gluten Intolerance Treatment Market Insights Summary:
Regional Insights:
- Europe is projected to command a 34% revenue share by 2035 in the gluten intolerance treatment market, attributed to increasing review of the broad spectrum of gluten-related disorders with focused clinical investigations, diagnostic criteria, and therapeutic approaches for different conditions causing gluten intolerance.
- Asia Pacific is anticipated to capture 25% of the gluten intolerance treatment market share by 2035, propelled by the growing concern about gluten intolerance among Asians, particularly across China and India.
Segment Insights:
- The celiac disease segment in the gluten intolerance treatment market is expected to account for a leading 40% revenue share by 2035, driven by the high prevalence of antibody-related gluten intolerance requiring targeted treatment solutions.
- The retail pharmacy segment is forecast to witness significant growth through 2035, impelled by the rise in demand for over-the-counter (OTC) medications.
Key Growth Trends:
- Growing Prevalence of Autoimmune, Allergic, and Non-autoimmune-allergic GRDs
- Rising Damage of Gut Flora or Dysbiosis
Major Challenges:
- Challenge Associated with Diagnosis
- Lack of Awareness
Key Players: IBM Corporation, HPE Symantec, CA Technologies, Mcafee Corporation, Oracle Corporation, Quest Software, NextLabs Inc., Veeam Software, Acronis International GmbH, Baffle Inc.
Global Gluten Intolerance Treatment Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 935.53 million
- 2026 Market Size: USD 1.05 billion
- Projected Market Size: USD 3.41 billion by 2035
- Growth Forecasts: 13.8% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: Europe (34% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, United Kingdom, Canada, Australia
- Emerging Countries: China, India, Japan, South Korea, Canada
Last updated on : 25 February, 2026
Gluten Intolerance Treatment Market - Growth Drivers and Challenges
Growth Drivers
-
Growing Prevalence of Autoimmune, Allergic, and Non-autoimmune-allergic GRDs – such as dermatitis herpetiformis (DH), celiac diseases, gluten ataxia (GA), wheat allergy (WA), and non-celiac gluten sensitivity (NCGS). As per some studies potentially over 41% of all people with ataxia of unknown origin may have gluten ataxia.
-
Rising Damage of Gut Flora or Dysbiosis – owing to the high usage of antibiotics or consuming food that they can’t digest. Gluten which is a protein is commonly found in wheat, barley, and other grains. Their increasing presence in a lot of processed foods and drinks, including pasta, cereal, and beer, and in things like vitamins, cosmetics, and even certain medications is responsible for the widespread gluten intolerance nowadays. In the United States, nearly 6% of the population is gluten intolerant.
- Increasing Research & Development – an international research team from Italy and France uncovered a new molecular player in the development of gluten intolerance. The discovery that is published in The EMBO Journal, suggests potential targets for the development of therapeutic approaches for the disease.
Challenges
-
Challenge Associated with Diagnosis – the same clinical manifestations for different GRDs that have specific pathophysiological responses to the ingestion of gluten can make their differential diagnosis challenging which is considered a major factor affecting the market growth.
-
Lack of Awareness
- Need for Customized Treatment
Gluten Intolerance Treatment Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
13.8% |
|
Base Year Market Size (2025) |
USD 935.53 million |
|
Forecast Year Market Size (2035) |
USD 3.41 billion |
|
Regional Scope |
|
Gluten Intolerance Treatment Market Segmentation:
Gluten-Related Disorders Segment Analysis
The celiac disease segment in the gluten intolerance treatment market is set to hold the largest revenue share of 40% by 2035. Celiac disease is one of the most common examples of several types of gluten intolerance and people with celiac disease also use gluten intolerance treatment as they have high levels of certain antibodies in their blood, which are substances that fight gluten.
The increasing prevalence of celiac disease which is a serious autoimmune disease where the ingestion of gluten leads to damage in the small intestine is also considered to propel the segment growth. According to a prediction, celiac disease affects 1 in 100 people worldwide, but only around 30% are properly diagnosed. Moreover, as gluten sensitivity and celiac disease cause a lot of the same symptoms, the increase in the disease share is expected to provide numerous growth opportunities to the market players.
Distribution Channel Segment Analysis
Gluten intolerance treatment market from the retail pharmacy segment is poised to register significant growth rate through 2035, owing to the rise in demand for over-the-counter (OTC) medications. Going forward most gluten-tolerance or allergy drugs need a prescription for an over-the-counter allergy drug which is predicted to be the major growth factor of the segment.
Our in-depth analysis of the market includes the following segments:
|
Type |
|
|
Gluten-Related Disorders |
|
|
Distribution Channel |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Gluten Intolerance Treatment Market - Regional Analysis
European Market Insights
Europe industry is predicted to dominate majority revenue share of 34% by 2035, due to increasing review of the broad spectrum of gluten-related disorders, with focused clinical investigations, diagnostic criteria, and therapeutic approaches for different conditions causing gluten intolerance.The increasing review of the broad spectrum of gluten-related disorders, with focused clinical investigations, diagnostic criteria, and therapeutic approaches for different conditions causing gluten intolerance will drive its treatment market in the region.
The prevalence of celiac disease, primarily in Northern European, specifically, in countries like Finland that have a relatively high rate of this condition is gradually leading the region towards improved methods of diagnosis and recognition and treatment of such conditions, bolstering the regional market expansion. Nearly 2.5% of all adults between the ages of 30 and 64 have been diagnosed with celiac disease in Finland.
APAC Market Insights
The Asia Pacific region is projected to account for 25% of the overall gluten intolerance treatment market share by 2035. The growing concern about gluten intolerance that is on the rise among Asians, especially among the population of China and India is anticipated to boost the market demand in the region.
China and India are the most populous countries in the world and the increasing evolution of modern farming practices for wheat cultivation, with advancements in food processing, has resulted in higher gluten content in wheat which is considered a major factor that will lead to the higher incidence of gluten intolerance in the region.
Gluten Intolerance Treatment Market Players:
- Takeda Pharmaceutical Company Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ActoBio Therapeutics, Inc.
- Precigen, Inc.
- Calypso Biotech BV
- ImmunogenX, Inc.
- Alvine Pharmaceuticals
- Dr. Falk Pharma GmbH
- ImmusanT, Inc.
- Zedira GmbH
- FunZyme BioTechnologies S.A.
- Amyra Biotech AG
Recent Developments
- ActoBio Therapeutics, Inc., a wholly-owned subsidiary of Intrexon Corporation announced that the U.S. Food and Drug Administration (FDA) has given its permission to an Investigational New Drug (IND) application for AG017. It is an innovative orally-delivered therapeutic candidate for the treatment of celiac disease.
- Takeda Pharmaceutical Company Limited, Zedira GmbH and Dr. Falk Pharma GmbH announced a collaboration and licensing agreement to develop ZED1227/TAK-227. TAK-227 is a Phase 2b investigational therapy for the treatment of celiac disease designed to prevent the immune response to gluten in celiac disease, a serious autoimmune disease where the ingestion of gluten leads to inflammation and damage to the small intestine.
- Report ID: 5081
- Published Date: Feb 25, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Gluten Intolerance Treatment Market Report Scope
Free Sample includes current and historical market size, growth trends, regional charts & tables, company profiles, segment-wise forecasts, and more.
Connect with our Expert
Copyright @ 2026 Research Nester. All Rights Reserved.
